1. Home
  2. NVAX vs NMZ Comparison

NVAX vs NMZ Comparison

Compare NVAX & NMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NMZ
  • Stock Information
  • Founded
  • NVAX 1987
  • NMZ 2003
  • Country
  • NVAX United States
  • NMZ United States
  • Employees
  • NVAX N/A
  • NMZ N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NMZ Finance/Investors Services
  • Sector
  • NVAX Health Care
  • NMZ Finance
  • Exchange
  • NVAX Nasdaq
  • NMZ Nasdaq
  • Market Cap
  • NVAX 1.3B
  • NMZ 1.2B
  • IPO Year
  • NVAX 1995
  • NMZ N/A
  • Fundamental
  • Price
  • NVAX $6.47
  • NMZ $10.21
  • Analyst Decision
  • NVAX Buy
  • NMZ
  • Analyst Count
  • NVAX 5
  • NMZ 0
  • Target Price
  • NVAX $16.60
  • NMZ N/A
  • AVG Volume (30 Days)
  • NVAX 6.2M
  • NMZ 356.8K
  • Earning Date
  • NVAX 08-07-2025
  • NMZ 01-01-0001
  • Dividend Yield
  • NVAX N/A
  • NMZ 5.08%
  • EPS Growth
  • NVAX N/A
  • NMZ N/A
  • EPS
  • NVAX 2.97
  • NMZ N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • NMZ N/A
  • Revenue This Year
  • NVAX $56.85
  • NMZ N/A
  • Revenue Next Year
  • NVAX N/A
  • NMZ N/A
  • P/E Ratio
  • NVAX $2.17
  • NMZ N/A
  • Revenue Growth
  • NVAX 25.92
  • NMZ N/A
  • 52 Week Low
  • NVAX $5.01
  • NMZ $8.26
  • 52 Week High
  • NVAX $17.81
  • NMZ $11.14
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 39.95
  • NMZ 39.80
  • Support Level
  • NVAX $6.26
  • NMZ $10.18
  • Resistance Level
  • NVAX $7.80
  • NMZ $10.31
  • Average True Range (ATR)
  • NVAX 0.36
  • NMZ 0.08
  • MACD
  • NVAX -0.13
  • NMZ -0.01
  • Stochastic Oscillator
  • NVAX 1.62
  • NMZ 11.11

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share

Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.

Share on Social Networks: